Diet drugs like Ozempic and Mounjaro are about to get a whole lot cheaper. Are we ready for a world where anyone can be thin?

Commenters are fuming after we cleaned our A2 with a garage brush, but I’ve had enough of the detailing police ...

Hongkonger Anjali Hazari used to run marathons and climb mountains before major knee and abdominal surgeries. Now she has a new challenge Anjali Hazari hit the ground running when she arrived in Hong ...

Ariel Messman-Rucker is an Oakland-born journalist who now calls the Pacific Northwest her home. When she’s not writing about politics and queer pop culture, she can be found reading, hiking, or ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated. By Simar Bajaj Taryn J. Mitchell, a 54-year-old banker from Greensboro, N.C ...

GRAND ISLAND, NE, UNITED STATES, January 20, 2026 /EINPresswire.com/ — Alternative Answers, a wellness practice based in Grand Island, Nebraska, is continuing to ...

When it comes to longevity, bigger is not always better. Aim for everyday strength. By Hilary Achauer These days, you might think you have to become a power lifter to age well. Dr. Gabrielle Lyon, a ...

Before Adam Sharples became a molecular physiologist studying muscle memory, he played professional rugby. Over his years as an athlete, he noticed that he and his teammates seemed to return to form ...

Screening of drug candidates and other compounds on human and animal muscle organs, including 3D human skeletal muscle, iPSC-derived systems, and neuromuscular junction models. We provide a ...

Despite the launch of its own premium brand Athiva, Chalet Hotels is sticking to its core model as a hotel developer and owner. But that does not mean an asset-light model is not possible in the ...

Russia announced Sunday that it had successfully tested a new nuclear-powered cruise missile, the 9M730 Burevestnik, or 'Storm Petrel.' It boasted that the missile, which can carry conventional or ...

Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, ...